IMUGENE LIMITED — Capital/Financing Update 2019

Nov 27, 2019

Market Announcement

==> picture [33 x 50] intentionally omitted <==

28 November 2019

==> picture [451 x 5] intentionally omitted <==

Imugene Limited (ASX: IMU) – Trading Halt

Description

The securities of Imugene Limited (‘IMU’) will be placed in trading halt at the request of IMU, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 2 December 2019 or when the announcement is released to the market.

Issued by

Cheng Tang

Senior Adviser, Listings Compliance (Melbourne)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

28 November 2019 ASX Limited

==> picture [116 x 42] intentionally omitted <==

Thursday, 28[th] November 2019

Cheng Tang ASX Compliance Pty Ltd Level 4, North Tower Rialto, 525 Collins Street, Melbourne, VIC. 3000

Sent via email: Cheng.Tang@asx.com.au

Dear Ms. Tang

Trading Halt Request

Pursuant to ASX Listing Rule 17.1, Imugene Limited (Company) requests a trading halt pending an announcement in relation to a proposed capital raising.

The trading halt will remain in place until the earlier of the commencement of normal trading on Monday 2[nd] December 2019, or until the release of the announcement in respect of the above matter.

The Company is not aware of any reason why the trading halt should not be granted.

For and on behalf of the Company,

Kind Regards;

==> picture [66 x 52] intentionally omitted <==

Phillip Hains Company Secretary Imugene Limited

IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com